A detailed history of Capital Planning Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 15,061 shares of ZTS stock, worth $2.66 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
15,061
Previous 14,478 4.03%
Holding current value
$2.66 Million
Previous $2.51 Million 17.26%
% of portfolio
0.46%
Previous 0.44%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$172.58 - $196.48 $100,614 - $114,547
583 Added 4.03%
15,061 $2.94 Million
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $165,333 - $203,150
-1,136 Reduced 7.28%
14,478 $2.51 Million
Q1 2024

May 15, 2024

SELL
$165.67 - $199.94 $5,301 - $6,398
-32 Reduced 0.2%
15,614 $2.64 Million
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $76,628 - $101,245
506 Added 3.34%
15,646 $3.09 Million
Q3 2023

Oct 30, 2023

SELL
$167.14 - $192.77 $8,858 - $10,216
-53 Reduced 0.35%
15,140 $2.63 Million
Q2 2023

Aug 01, 2023

SELL
$160.94 - $186.23 $17,703 - $20,485
-110 Reduced 0.72%
15,193 $2.62 Million
Q1 2023

May 15, 2023

SELL
$145.48 - $175.02 $44,225 - $53,206
-304 Reduced 1.95%
15,303 $2.55 Million
Q4 2022

Feb 09, 2023

SELL
$131.14 - $157.47 $66,225 - $79,522
-505 Reduced 3.13%
15,607 $2.29 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $54,719 - $67,360
369 Added 2.34%
16,112 $2.39 Million
Q2 2022

Aug 10, 2022

SELL
$155.97 - $200.09 $14,037 - $18,008
-90 Reduced 0.57%
15,743 $2.71 Million
Q1 2022

May 10, 2022

BUY
$181.39 - $234.03 $45,891 - $59,209
253 Added 1.62%
15,833 $2.99 Million
Q4 2021

Feb 14, 2022

BUY
$193.69 - $247.03 $31,765 - $40,512
164 Added 1.06%
15,580 $3.8 Million
Q3 2021

Nov 09, 2021

SELL
$189.29 - $209.69 $22,904 - $25,372
-121 Reduced 0.78%
15,416 $2.99 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $42,093 - $50,757
270 Added 1.77%
15,537 $2.9 Million
Q1 2021

Apr 30, 2021

BUY
$144.0 - $169.39 $323,280 - $380,280
2,245 Added 17.24%
15,267 $2.4 Million
Q4 2020

Feb 04, 2021

SELL
$157.07 - $174.35 $96,283 - $106,876
-613 Reduced 4.5%
13,022 $2.16 Million
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $51,412 - $62,013
375 Added 2.83%
13,635 $2.26 Million
Q2 2020

Aug 06, 2020

BUY
$111.92 - $142.53 $240,516 - $306,296
2,149 Added 19.34%
13,260 $1.82 Million
Q1 2020

May 11, 2020

SELL
$92.66 - $144.94 $2,687 - $4,203
-29 Reduced 0.26%
11,111 $1.31 Million
Q4 2019

Feb 03, 2020

BUY
$116.25 - $133.25 $822,468 - $942,743
7,075 Added 174.05%
11,140 $1.47 Million
Q3 2019

Nov 05, 2019

BUY
$112.57 - $128.43 $457,597 - $522,067
4,065 New
4,065 $506,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Capital Planning Advisors, LLC Portfolio

Follow Capital Planning Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.